Market Tracker

10/24 5:18am ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

128.02
Data as of Oct 23
 -0.75 / -0.58%
Today’s Change
102.60
Today|||52-Week Range
153.10
+9.05%
Year-to-Date

Today’s Trading

Previous close128.77
Today’s open129.68
Day’s range-- - --
Volume2,088,599
Average volume (3 months)2,873,510
Market cap$43.0B
Dividend yield--
Data as of 10/23/2014

Growth & Valuation

Earnings growth (last year)-610.53%
Earnings growth (this year)+32.06%
Earnings growth (next 5 years)+32.50%
Revenue growth (last year)+62.68%
P/E ratio--
Price/Sales6.53
Price/Book8.38

Competitors

 Today’s
change
Today’s
% change
SHPGShire PLC+0.19+0.10%
ALXNAlexion Pharmaceutic...+12.65+7.30%
AGNAllergan Inc+0.56+0.31%
VRTXVertex Pharmaceutica...+1.92+1.81%
Data as of 10/23/2014

Financials

Last reporting dateOctober 20, 2014
EPS forecast (this quarter)$2.11
Annual revenue (last year)$5.8B
Annual profit (last year)-$866.1M
Net profit margin-15.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts